FREE Account Opening + No Clearing Fees
Loading...

Bafna Pharmaceuticals IPO vs Niraj Cement Structurals IPO

Comparision between Bafna Pharmaceuticals IPO and Niraj Cement Structurals IPO.

IPO Details

Bafna Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE while Niraj Cement Structurals IPO is a Mainline Book Built Issue proposed to list at BSE.

  Bafna Pharmaceuticals IPO Niraj Cement Structurals IPO
Logo Bafna Pharmaceuticals IPO Logo Niraj Cement Structurals IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE BSE
Lead Managers Keynote Financial Services Ltd

Ashika Capital Ltd
Allahabad Bank
Registrar Cameo Corporate Services Limited Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the Niraj Cement Structurals IPO is up to ₹61.75 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of Niraj Cement Structurals IPO is ₹190.00 per share.

  Bafna Pharmaceuticals IPO Niraj Cement Structurals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹175.00 per share
Issue Price (Upper) ₹190.00 per share
Issue Price (Final) ₹40.00 per share ₹190.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 30 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 64,00,000 shares 32,50,000 shares
Issue Size Total (Amount) up to ₹25.60 Cr up to ₹61.75 Cr

IPO Timetable

Bafna Pharmaceuticals IPO opens on May 27, 2008, while Niraj Cement Structurals IPO opens on May 26, 2008. The closing date of Bafna Pharmaceuticals IPO and Niraj Cement Structurals IPO is May 30, 2008, and May 30, 2008, respectively.

  Bafna Pharmaceuticals IPO Niraj Cement Structurals IPO
Anchor Bid Date
Issue Open May 27, 2008 May 26, 2008
Issue Close May 30, 2008 May 30, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Bafna Pharmaceuticals IPO P/E ratio is , as compared to Niraj Cement Structurals IPO P/E ratio of .

  Bafna Pharmaceuticals IPO Niraj Cement Structurals IPO
Financial
ParticularsFor the year/period ended (Rs. in lacs)
 30-Jun-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income432.023861.962136.472662.651521.33
  Profit After Tax (PAT)49.70104.2392.2789.8144.51
ParticularsFor the year/period ended (Rs. in lacs)
 31-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income7,966.027,039.573,157.283,285.88
  Profit After Tax (PAT)637.53779.49160.11253.51
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Bafna Pharmaceuticals IPO retail investors (RII) are offered while in Niraj Cement Structurals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bafna Pharmaceuticals IPO and in Niraj Cement Structurals IPO.

  Bafna Pharmaceuticals IPO Niraj Cement Structurals IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Bafna Pharmaceuticals IPO subscribed in total, whereas Niraj Cement Structurals IPO subscribed 1.74x.

  Bafna Pharmaceuticals IPO Niraj Cement Structurals IPO
QIB (times) 0.00x
NII (times) 4.01x
Big NII (times)
Small NII (times)
RII (times) 3.81x
Employee (times) 0.00x
Other (times)
Total (times) 1.74x

Comments

Add a public comment...